MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines
Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to r...
Saved in:
Published in | Scientific reports Vol. 11; no. 1; pp. 14772 - 11 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
20.07.2021
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (
Men1
+/−
) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in
Men1
+/−
compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of
Men1
in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies. |
---|---|
AbstractList | Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1(+/-)) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1(+/-) compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies. Abstract Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1 +/−) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1 +/− compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies. Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice ( Men1 +/− ) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1 +/− compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies. Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1+/-) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1+/- compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies.Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1+/-) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1+/- compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies. Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant tumors are accumulating, knowledge of molecular events of importance for initiation of adrenocortical transformation is scarce. In an attempt to recognize early molecular alterations, we used adrenals from young multiple endocrine neoplasia type 1 conventional knock-out mice (Men1+/−) closely mimicking the human MEN1 trait (i.e. transformation of pituitary, parathyroid, endocrine pancreatic, and adrenocortical cells). MicroRNA array and hierarchical clustering showed a distinct pattern. Twenty miRNAs were significantly upregulated and eleven were downregulated in Men1+/− compared to wild type littermates. The latter included the known suppressor miRNA miR-486-3p, which was chosen for transfection in human adrenocortical carcinoma cell lines H295R and SW13. Cell growth decreased in miR-486-3p overexpressing clones and levels of the predicted target gene fatty acid synthase (FASN) and its downstream product, palmitic acid, were lowered. In conclusion, heterozygous inactivation of Men1 in adrenals results in distinct miRNA profile regulating expression of genes with impact on tumorigenesis, e.g. transcription, nucleic acid and lipid metabolism. Low levels of miR-486-3p in the early stages of transformation may contribute to proliferation by increasing FASN and thus fatty acid production. FASN as a potentially druggable target for treatment of the devastating disease adrenocortical carcinoma warrants further studies. |
ArticleNumber | 14772 |
Author | Skogseid, Britt Monazzam, Azita Li, Su-Chen Razmara, Masoud Chu, Xia Stålberg, Peter |
Author_xml | – sequence: 1 givenname: Su-Chen surname: Li fullname: Li, Su-Chen organization: Department of Medical Sciences, Uppsala University – sequence: 2 givenname: Azita surname: Monazzam fullname: Monazzam, Azita organization: Department of Medical Sciences, Uppsala University – sequence: 3 givenname: Masoud surname: Razmara fullname: Razmara, Masoud organization: Department of Medical Sciences, Uppsala University – sequence: 4 givenname: Xia surname: Chu fullname: Chu, Xia organization: Department of Medical Sciences, Uppsala University – sequence: 5 givenname: Peter surname: Stålberg fullname: Stålberg, Peter organization: Department of Surgical Sciences, Uppsala University – sequence: 6 givenname: Britt surname: Skogseid fullname: Skogseid, Britt email: britt.skogseid@medsci.uu.se organization: Department of Medical Sciences, Uppsala University, Science for Life Laboratory in Uppsala |
BackLink | https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456302$$DView record from Swedish Publication Index |
BookMark | eNp9ks9u1DAQxiNUREvpC3CyxIVDA44dZ-0LUtXyp1IBqQKu1sSebF0ldrATqvZ1eFGc3UXQHhpZysj-vt_YM_O82PPBY1G8rOibinL5NtWVULKkrCpVDuvy7klxwGgtSsYZ2_sv3i-OUrqm-RMsS9WzYp_XTIq8Dorfn91lWcum5CO5gURsuPER13MPE1oCExmcieHyywkZY-hc7_yahI6AjeihT0s8zP3kxh4JehtMdB6JxzD2kByQ6XZEUi0UPCbgLXH-yrVugV_NA_gtKZgQJ2egJwaicT4MQAz2Pcn5ML0onnY5Fx7t_ofF9w_vv51-Ki--fjw_PbkojRD1VAqJrbINY8BaUFI0Blaiba3N5bI0P1wq23HbGWiY6GqgbauA2qxVKKGj_LA433JtgGs9RjdAvNUBnN5shLjWsFyzR91yuaosrHi9UjXWIHnToqVgQSDrzCqzjresdIPj3N6jnbkfJxvaPOtaNJyyLH-3lWftgNagnyL091z3T7y70uvwS0umGG-aDHi9A8Twc8Y06cGlpYSQezEnzYTgslKNWnK9eiC9DnNcurlRcSVpvQDlVpXbn1LEThs3weTCkt_1uqJ6mUO9nUOd51Bv5lDfZSt7YP37jkdNfFewLPZrjP9u9YjrDy219PU |
CitedBy_id | crossref_primary_10_1080_15384047_2024_2428469 crossref_primary_10_7717_peerj_16930 crossref_primary_10_1002_mc_23879 crossref_primary_10_1097_MD_0000000000036908 crossref_primary_10_3389_fgene_2023_1137017 |
Cites_doi | 10.1530/JME-18-0262 10.1038/ng.2953 10.1016/j.bbcan.2012.03.001 10.1038/nrg2843 10.1038/nature06487 10.1038/jid.2014.479 10.1136/gut.2006.108910 10.1210/jcem.84.1.5388 10.1016/j.humpath.2005.11.022 10.1371/journal.pone.0087951 10.1007/s13277-014-2412-0 10.1007/s11745-004-1329-9 10.1038/labinvest.2010.157 10.1210/en.2011-1924 10.1002/cncr.25724 10.1186/s12944-019-1058-8 10.1530/ERC-11-0082 10.1097/PAI.0000000000000117 10.1200/JCO.2005.05.5194 10.1126/science.276.5311.404 10.1016/0002-9343(54)90353-8 10.1210/jcem.75.1.1352309 10.1038/ng865 10.1002/hep.26662 10.3892/ol.2017.7598 10.1101/gad.949001 10.1210/jc.2014-3282 10.1128/mcb.23.17.6075-6085.2003 10.1073/pnas.011404098 10.1677/ERC-09-0096 10.1016/j.bbrc.2013.01.016 10.1093/nar/gkv007 10.1038/nrg1379 10.1158/0008-5472.CAN-11-4112 10.1006/meth.2001.1262 10.1002/ijc.22288 10.1158/1078-0432.CCR-10-3152 10.1016/j.ccell.2016.04.002 10.1210/jc.2018-00817 10.1038/onc.2009.192 10.1016/j.cell.2009.01.002 10.1016/j.bbrc.2011.02.065 10.1016/s0092-8674(04)00045-5 10.1158/0008-5472.CAN-09-3970 10.1158/0008-5472.CAN-10-3221 10.1007/s00423-006-0124-7 10.1111/j.2517-6161.1995.tb02031.x 10.3322/caac.21244 10.2202/1544-6115.1027 10.1530/EJE-11-0679 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021. The Author(s). |
Copyright_xml | – notice: The Author(s) 2021 – notice: The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021. The Author(s). |
DBID | C6C AAYXX CITATION 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 5PM ACNBI ADTPV AOWAS D8T DF2 ZZAVC DOA |
DOI | 10.1038/s41598-021-94154-z |
DatabaseName | Springer Nature OA Free Journals CrossRef ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central ProQuest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) SWEPUB Uppsala universitet full text SwePub SwePub Articles SWEPUB Freely available online SWEPUB Uppsala universitet SwePub Articles full text DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen Free (Free internet resource, activated by CARLI) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_b3871da734794e4a836bed0ada5e2fc7 oai_DiVA_org_uu_456302 PMC8292366 10_1038_s41598_021_94154_z |
GrantInformation_xml | – fundername: Uppsala University – fundername: Cancerfonden grantid: CAN 2017/768 funderid: http://dx.doi.org/10.13039/501100002794 – fundername: Vetenskapsrådet grantid: 2015–4870 funderid: http://dx.doi.org/10.13039/501100004359 – fundername: ; – fundername: ; grantid: CAN 2017/768 – fundername: ; grantid: 2015–4870 |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT 7XB 8FK AARCD K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PRINS Q9U 7X8 5PM ACNBI ADTPV AOWAS D8T DF2 EJD IPNFZ RIG ZZAVC PUEGO |
ID | FETCH-LOGICAL-c554t-58eb9d622a2ba9856ca75bbdd038d041989df3dfca625f4a0bb9a0dba99e8af03 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Wed Aug 27 01:27:04 EDT 2025 Thu Aug 21 07:03:30 EDT 2025 Thu Aug 21 18:22:16 EDT 2025 Fri Jul 11 06:52:33 EDT 2025 Wed Aug 13 10:54:23 EDT 2025 Thu Apr 24 22:55:09 EDT 2025 Tue Jul 01 03:48:55 EDT 2025 Fri Feb 21 02:38:56 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c554t-58eb9d622a2ba9856ca75bbdd038d041989df3dfca625f4a0bb9a0dba99e8af03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1038/s41598-021-94154-z |
PMID | 34285285 |
PQID | 2553398046 |
PQPubID | 2041939 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b3871da734794e4a836bed0ada5e2fc7 swepub_primary_oai_DiVA_org_uu_456302 pubmedcentral_primary_oai_pubmedcentral_nih_gov_8292366 proquest_miscellaneous_2553819692 proquest_journals_2553398046 crossref_citationtrail_10_1038_s41598_021_94154_z crossref_primary_10_1038_s41598_021_94154_z springer_journals_10_1038_s41598_021_94154_z |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-07-20 |
PublicationDateYYYYMMDD | 2021-07-20 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-20 day: 20 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationYear | 2021 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group – name: Nature Portfolio |
References | Wang (CR39) 2011; 71 Bartel (CR17) 2009; 136 CR37 Zecchin (CR47) 2011; 91 Pizer (CR45) 2000; 60 Heppner (CR8) 1999; 84 Doghman (CR30) 2010; 70 Loffler (CR5) 2007; 120 Crabtree (CR4) 2003; 23 Ritchie (CR49) 2015; 43 Livak, Schmittgen (CR52) 2001; 25 Zaidi, Swinnen, Smans (CR41) 2012; 72 Tian, Li, Sheng, Jin (CR42) 2018; 15 Wermer (CR1) 1954; 16 Waldmann (CR3) 2007; 392 Ozata (CR16) 2011; 18 Patterson, Holloway, Weng, Fojo, Kebebew (CR31) 2011; 117 Lim (CR27) 2014; 59 Roldo (CR19) 2006; 24 Decmann (CR36) 2018; 103 Park (CR26) 2011; 406 Zheng (CR10) 2016; 29 Zhang, Liu, Cui, Wang, Yang (CR33) 2014; 35 Penna, Orso, Taverna (CR38) 2015; 135 Nicolson, Korah, Carling (CR11) 2019; 62 Juhlin (CR14) 2015; 100 Chang (CR43) 2019; 18 Chandrasekharappa (CR6) 1997; 276 Zhang, Zhao, Gao, Zhang (CR35) 1826; 32–43 Shah (CR46) 2006; 37 Krol, Loedige, Filipowicz (CR18) 2010; 11 Bartel (CR22) 2004; 116 Lee (CR28) 2009; 28 Li, Wong (CR48) 2001; 98 CR50 Tombol (CR29) 2009; 16 Benjamini, Hochberg (CR51) 1995; 57 Skogseid (CR2) 1992; 75 Lai (CR21) 2002; 30 Li, Zhu, Xu, Wang, Yan (CR32) 2013; 431 Feinmesser (CR34) 2015; 23 Oh (CR40) 2011; 17 Assie (CR9) 2014; 46 CR25 CR24 Quon, Berns (CR7) 2001; 15 Lejonklou, Barbu, Stalberg, Skogseid (CR13) 2012; 153 Chirala, Wakil (CR44) 2004; 39 He, Hannon (CR23) 2004; 5 Kjellin (CR15) 2014; 9 Tavazoie (CR20) 2008; 451 Anlauf (CR12) 2007; 56 EE Patterson (94154_CR31) 2011; 117 L Lim (94154_CR27) 2014; 59 NG Nicolson (94154_CR11) 2019; 62 J Krol (94154_CR18) 2010; 11 ES Pizer (94154_CR45) 2000; 60 DP Bartel (94154_CR22) 2004; 116 Y Li (94154_CR32) 2013; 431 ME Ritchie (94154_CR49) 2015; 43 M Doghman (94154_CR30) 2010; 70 C Li (94154_CR48) 2001; 98 EC Lai (94154_CR21) 2002; 30 Y Wang (94154_CR39) 2011; 71 P Wermer (94154_CR1) 1954; 16 C Heppner (94154_CR8) 1999; 84 KJ Livak (94154_CR52) 2001; 25 L He (94154_CR23) 2004; 5 N Zaidi (94154_CR41) 2012; 72 JS Crabtree (94154_CR4) 2003; 23 S Tian (94154_CR42) 2018; 15 94154_CR50 SC Chandrasekharappa (94154_CR6) 1997; 276 H Kjellin (94154_CR15) 2014; 9 CC Juhlin (94154_CR14) 2015; 100 Z Tombol (94154_CR29) 2009; 16 US Shah (94154_CR46) 2006; 37 Y Benjamini (94154_CR51) 1995; 57 DP Bartel (94154_CR17) 2009; 136 L Chang (94154_CR43) 2019; 18 94154_CR24 KH Lee (94154_CR28) 2009; 28 94154_CR25 DM Ozata (94154_CR16) 2011; 18 M Feinmesser (94154_CR34) 2015; 23 KC Quon (94154_CR7) 2001; 15 C Roldo (94154_CR19) 2006; 24 SF Tavazoie (94154_CR20) 2008; 451 G Assie (94154_CR9) 2014; 46 MH Lejonklou (94154_CR13) 2012; 153 J Waldmann (94154_CR3) 2007; 392 HK Oh (94154_CR40) 2011; 17 KA Loffler (94154_CR5) 2007; 120 SS Chirala (94154_CR44) 2004; 39 B Skogseid (94154_CR2) 1992; 75 KG Zecchin (94154_CR47) 2011; 91 94154_CR37 M Anlauf (94154_CR12) 2007; 56 A Decmann (94154_CR36) 2018; 103 E Penna (94154_CR38) 2015; 135 G Zhang (94154_CR33) 2014; 35 S Zheng (94154_CR10) 2016; 29 J Zhang (94154_CR35) 1826; 32–43 JK Park (94154_CR26) 2011; 406 |
References_xml | – volume: 62 start-page: 179 year: 2019 end-page: 186 ident: CR11 article-title: Adrenocortical cancer cell line mutational profile reveals aggressive genetic background publication-title: J. Mol. Endocrinol. doi: 10.1530/JME-18-0262 – volume: 60 start-page: 213 year: 2000 end-page: 218 ident: CR45 article-title: Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts publication-title: Cancer Res – volume: 46 start-page: 607 year: 2014 end-page: 612 ident: CR9 article-title: Integrated genomic characterization of adrenocortical carcinoma publication-title: Nat. Genet doi: 10.1038/ng.2953 – volume: 32–43 start-page: 2012 year: 1826 ident: CR35 article-title: Secretory miRNAs as novel cancer biomarkers publication-title: Biochim Biophys Acta doi: 10.1016/j.bbcan.2012.03.001 – volume: 11 start-page: 597 year: 2010 end-page: 610 ident: CR18 article-title: The widespread regulation of microRNA biogenesis, function and decay publication-title: Nat. Rev. Genet. doi: 10.1038/nrg2843 – volume: 451 start-page: 147 year: 2008 end-page: 152 ident: CR20 article-title: Endogenous human microRNAs that suppress breast cancer metastasis publication-title: Nature doi: 10.1038/nature06487 – volume: 135 start-page: 960 year: 2015 end-page: 969 ident: CR38 article-title: miR-214 as a key hub that controls cancer networks: small player, multiple functions publication-title: J. Invest Dermatol. doi: 10.1038/jid.2014.479 – volume: 56 start-page: 637 year: 2007 end-page: 644 ident: CR12 article-title: Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions publication-title: Gut doi: 10.1136/gut.2006.108910 – ident: CR25 – volume: 84 start-page: 216 year: 1999 end-page: 219 ident: CR8 article-title: MEN1 gene analysis in sporadic adrenocortical neoplasms publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.84.1.5388 – volume: 37 start-page: 401 year: 2006 end-page: 409 ident: CR46 article-title: Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma publication-title: Hum. Pathol. doi: 10.1016/j.humpath.2005.11.022 – volume: 9 year: 2014 ident: CR15 article-title: Differentially expressed proteins in malignant and benign adrenocortical tumors publication-title: PLoS ONE doi: 10.1371/journal.pone.0087951 – volume: 35 start-page: 11137 year: 2014 end-page: 11145 ident: CR33 article-title: MicroRNA-486-5p targeting PIM-1 suppresses cell proliferation in breast cancer cells publication-title: Tumour Biol. doi: 10.1007/s13277-014-2412-0 – volume: 39 start-page: 1045 year: 2004 end-page: 1053 ident: CR44 article-title: Structure and function of animal fatty acid synthase publication-title: Lipids doi: 10.1007/s11745-004-1329-9 – volume: 91 start-page: 232 year: 2011 end-page: 240 ident: CR47 article-title: Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis publication-title: Lab Invest. doi: 10.1038/labinvest.2010.157 – volume: 153 start-page: 2588 year: 2012 end-page: 2598 ident: CR13 article-title: Accelerated proliferation and differential global gene expression in pancreatic islets of five-week-old heterozygous Men1 mice: Men1 is a haploinsufficient suppressor publication-title: Endocrinology doi: 10.1210/en.2011-1924 – ident: CR50 – volume: 117 start-page: 1630 year: 2011 end-page: 1639 ident: CR31 article-title: MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy publication-title: Cancer doi: 10.1002/cncr.25724 – volume: 18 start-page: 118 year: 2019 ident: CR43 article-title: Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway publication-title: Lipids Health Dis. doi: 10.1186/s12944-019-1058-8 – volume: 18 start-page: 643 year: 2011 end-page: 655 ident: CR16 article-title: The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma publication-title: Endocr. Relat. Cancer doi: 10.1530/ERC-11-0082 – volume: 23 start-page: 522 year: 2015 end-page: 531 ident: CR34 article-title: Specific microRNAs differentiate adrenocortical adenomas from carcinomas and correlate with weiss histopathologic system publication-title: Appl Immunohistochem Mol Morphol doi: 10.1097/PAI.0000000000000117 – volume: 24 start-page: 4677 year: 2006 end-page: 4684 ident: CR19 article-title: MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.05.5194 – volume: 276 start-page: 404 year: 1997 end-page: 407 ident: CR6 article-title: Positional cloning of the gene for multiple endocrine neoplasia-type 1 publication-title: Science doi: 10.1126/science.276.5311.404 – volume: 16 start-page: 363 year: 1954 end-page: 371 ident: CR1 article-title: Genetic aspects of adenomatosis of endocrine glands publication-title: Am. J. Med. doi: 10.1016/0002-9343(54)90353-8 – volume: 75 start-page: 76 year: 1992 end-page: 81 ident: CR2 article-title: Clinical and genetic features of adrenocortical lesions in multiple endocrine neoplasia type 1 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.75.1.1352309 – volume: 30 start-page: 363 year: 2002 end-page: 364 ident: CR21 article-title: Micro RNAs are complementary to 3' UTR sequence motifs that mediate negative post-transcriptional regulation publication-title: Nat. Genet. doi: 10.1038/ng865 – volume: 59 start-page: 202 year: 2014 end-page: 215 ident: CR27 article-title: MicroRNA-494 within an oncogenic microRNA megacluster regulates G1/S transition in liver tumorigenesis through suppression of mutated in colorectal cancer publication-title: Hepatology doi: 10.1002/hep.26662 – ident: CR37 – volume: 15 start-page: 2211 year: 2018 end-page: 2217 ident: CR42 article-title: Upregulation of pyruvate kinase M2 expression by fatty acid synthase contributes to gemcitabine resistance in pancreatic cancer publication-title: Oncol. Lett. doi: 10.3892/ol.2017.7598 – volume: 15 start-page: 2917 year: 2001 end-page: 2921 ident: CR7 article-title: Haplo-insufficiency? Let me count the ways publication-title: Genes Dev. doi: 10.1101/gad.949001 – volume: 100 start-page: E493 year: 2015 end-page: 502 ident: CR14 article-title: Whole-exome sequencing characterizes the landscape of somatic mutations and copy number alterations in adrenocortical carcinoma publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2014-3282 – volume: 23 start-page: 6075 year: 2003 end-page: 6085 ident: CR4 article-title: Of mice and MEN1: Insulinomas in a conditional mouse knockout publication-title: Mol. Cell. Biol. doi: 10.1128/mcb.23.17.6075-6085.2003 – volume: 98 start-page: 31 year: 2001 end-page: 36 ident: CR48 article-title: Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection publication-title: Proc. Natl. Acad. Sci. U S A doi: 10.1073/pnas.011404098 – volume: 57 start-page: 289 year: 1995 end-page: 300 ident: CR51 article-title: Controlling the false discovery rate: a practical and powerful approach to multiple testing publication-title: J R Stat Soc B – volume: 16 start-page: 895 year: 2009 end-page: 906 ident: CR29 article-title: Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis publication-title: Endocr. Relat. Cancer doi: 10.1677/ERC-09-0096 – volume: 431 start-page: 560 year: 2013 end-page: 565 ident: CR32 article-title: miR-330 regulates the proliferation of colorectal cancer cells by targeting Cdc42 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2013.01.016 – volume: 43 year: 2015 ident: CR49 article-title: limma powers differential expression analyses for RNA-sequencing and microarray studies publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv007 – volume: 5 start-page: 522 year: 2004 end-page: 531 ident: CR23 article-title: MicroRNAs: small RNAs with a big role in gene regulation publication-title: Nat. Rev. Genet. doi: 10.1038/nrg1379 – volume: 72 start-page: 3709 year: 2012 end-page: 3714 ident: CR41 article-title: ATP-citrate lyase: a key player in cancer metabolism publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-4112 – volume: 25 start-page: 402 year: 2001 end-page: 408 ident: CR52 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 120 start-page: 259 year: 2007 end-page: 267 ident: CR5 article-title: Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1 publication-title: Int. J. Cancer doi: 10.1002/ijc.22288 – volume: 17 start-page: 2657 year: 2011 end-page: 2667 ident: CR40 article-title: Genomic loss of miR-486 regulates tumor progression and the OLFM4 antiapoptotic factor in gastric cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-3152 – volume: 29 start-page: 723 year: 2016 end-page: 736 ident: CR10 article-title: Comprehensive pan-genomic characterization of adrenocortical carcinoma publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.04.002 – volume: 103 start-page: 3522 year: 2018 end-page: 3530 ident: CR36 article-title: MicroRNA expression profiling in adrenal myelolipoma publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2018-00817 – volume: 28 start-page: 3360 year: 2009 end-page: 3370 ident: CR28 article-title: MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation publication-title: Oncogene doi: 10.1038/onc.2009.192 – volume: 136 start-page: 215 year: 2009 end-page: 233 ident: CR17 article-title: MicroRNAs: target recognition and regulatory functions publication-title: Cell doi: 10.1016/j.cell.2009.01.002 – volume: 406 start-page: 518 year: 2011 end-page: 523 ident: CR26 article-title: miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.02.065 – volume: 116 start-page: 281 year: 2004 end-page: 297 ident: CR22 article-title: MicroRNAs: genomics, biogenesis, mechanism, and function publication-title: Cell doi: 10.1016/s0092-8674(04)00045-5 – volume: 70 start-page: 4666 year: 2010 end-page: 4675 ident: CR30 article-title: Regulation of insulin-like growth factor-mammalian target of rapamycin signaling by microRNA in childhood adrenocortical tumors publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3970 – ident: CR24 – volume: 71 start-page: 371 year: 2011 end-page: 382 ident: CR39 article-title: The tumor suppressor protein menin inhibits AKT activation by regulating its cellular localization publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-3221 – volume: 392 start-page: 437 year: 2007 end-page: 443 ident: CR3 article-title: Adrenal involvement in multiple endocrine neoplasia type 1: results of 7 years prospective screening publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-006-0124-7 – volume: 100 start-page: E493 year: 2015 ident: 94154_CR14 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2014-3282 – volume: 24 start-page: 4677 year: 2006 ident: 94154_CR19 publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.05.5194 – volume: 431 start-page: 560 year: 2013 ident: 94154_CR32 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2013.01.016 – volume: 30 start-page: 363 year: 2002 ident: 94154_CR21 publication-title: Nat. Genet. doi: 10.1038/ng865 – volume: 25 start-page: 402 year: 2001 ident: 94154_CR52 publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 71 start-page: 371 year: 2011 ident: 94154_CR39 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-10-3221 – volume: 18 start-page: 118 year: 2019 ident: 94154_CR43 publication-title: Lipids Health Dis. doi: 10.1186/s12944-019-1058-8 – volume: 23 start-page: 522 year: 2015 ident: 94154_CR34 publication-title: Appl Immunohistochem Mol Morphol doi: 10.1097/PAI.0000000000000117 – volume: 75 start-page: 76 year: 1992 ident: 94154_CR2 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.75.1.1352309 – volume: 392 start-page: 437 year: 2007 ident: 94154_CR3 publication-title: Langenbecks Arch Surg doi: 10.1007/s00423-006-0124-7 – volume: 103 start-page: 3522 year: 2018 ident: 94154_CR36 publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2018-00817 – volume: 32–43 start-page: 2012 year: 1826 ident: 94154_CR35 publication-title: Biochim Biophys Acta doi: 10.1016/j.bbcan.2012.03.001 – volume: 57 start-page: 289 year: 1995 ident: 94154_CR51 publication-title: J R Stat Soc B doi: 10.1111/j.2517-6161.1995.tb02031.x – volume: 37 start-page: 401 year: 2006 ident: 94154_CR46 publication-title: Hum. Pathol. doi: 10.1016/j.humpath.2005.11.022 – volume: 406 start-page: 518 year: 2011 ident: 94154_CR26 publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2011.02.065 – volume: 84 start-page: 216 year: 1999 ident: 94154_CR8 publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jcem.84.1.5388 – volume: 9 year: 2014 ident: 94154_CR15 publication-title: PLoS ONE doi: 10.1371/journal.pone.0087951 – volume: 117 start-page: 1630 year: 2011 ident: 94154_CR31 publication-title: Cancer doi: 10.1002/cncr.25724 – volume: 276 start-page: 404 year: 1997 ident: 94154_CR6 publication-title: Science doi: 10.1126/science.276.5311.404 – ident: 94154_CR24 – volume: 16 start-page: 363 year: 1954 ident: 94154_CR1 publication-title: Am. J. Med. doi: 10.1016/0002-9343(54)90353-8 – volume: 70 start-page: 4666 year: 2010 ident: 94154_CR30 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3970 – volume: 29 start-page: 723 year: 2016 ident: 94154_CR10 publication-title: Cancer Cell doi: 10.1016/j.ccell.2016.04.002 – volume: 451 start-page: 147 year: 2008 ident: 94154_CR20 publication-title: Nature doi: 10.1038/nature06487 – volume: 135 start-page: 960 year: 2015 ident: 94154_CR38 publication-title: J. Invest Dermatol. doi: 10.1038/jid.2014.479 – volume: 5 start-page: 522 year: 2004 ident: 94154_CR23 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg1379 – ident: 94154_CR25 doi: 10.3322/caac.21244 – volume: 39 start-page: 1045 year: 2004 ident: 94154_CR44 publication-title: Lipids doi: 10.1007/s11745-004-1329-9 – volume: 15 start-page: 2917 year: 2001 ident: 94154_CR7 publication-title: Genes Dev. doi: 10.1101/gad.949001 – volume: 59 start-page: 202 year: 2014 ident: 94154_CR27 publication-title: Hepatology doi: 10.1002/hep.26662 – volume: 98 start-page: 31 year: 2001 ident: 94154_CR48 publication-title: Proc. Natl. Acad. Sci. U S A doi: 10.1073/pnas.011404098 – volume: 15 start-page: 2211 year: 2018 ident: 94154_CR42 publication-title: Oncol. Lett. doi: 10.3892/ol.2017.7598 – volume: 23 start-page: 6075 year: 2003 ident: 94154_CR4 publication-title: Mol. Cell. Biol. doi: 10.1128/mcb.23.17.6075-6085.2003 – volume: 91 start-page: 232 year: 2011 ident: 94154_CR47 publication-title: Lab Invest. doi: 10.1038/labinvest.2010.157 – volume: 72 start-page: 3709 year: 2012 ident: 94154_CR41 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-4112 – volume: 60 start-page: 213 year: 2000 ident: 94154_CR45 publication-title: Cancer Res – volume: 116 start-page: 281 year: 2004 ident: 94154_CR22 publication-title: Cell doi: 10.1016/s0092-8674(04)00045-5 – volume: 43 year: 2015 ident: 94154_CR49 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkv007 – volume: 11 start-page: 597 year: 2010 ident: 94154_CR18 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg2843 – volume: 62 start-page: 179 year: 2019 ident: 94154_CR11 publication-title: J. Mol. Endocrinol. doi: 10.1530/JME-18-0262 – volume: 18 start-page: 643 year: 2011 ident: 94154_CR16 publication-title: Endocr. Relat. Cancer doi: 10.1530/ERC-11-0082 – ident: 94154_CR50 doi: 10.2202/1544-6115.1027 – volume: 153 start-page: 2588 year: 2012 ident: 94154_CR13 publication-title: Endocrinology doi: 10.1210/en.2011-1924 – ident: 94154_CR37 doi: 10.1530/EJE-11-0679 – volume: 56 start-page: 637 year: 2007 ident: 94154_CR12 publication-title: Gut doi: 10.1136/gut.2006.108910 – volume: 120 start-page: 259 year: 2007 ident: 94154_CR5 publication-title: Int. J. Cancer doi: 10.1002/ijc.22288 – volume: 46 start-page: 607 year: 2014 ident: 94154_CR9 publication-title: Nat. Genet doi: 10.1038/ng.2953 – volume: 16 start-page: 895 year: 2009 ident: 94154_CR29 publication-title: Endocr. Relat. Cancer doi: 10.1677/ERC-09-0096 – volume: 17 start-page: 2657 year: 2011 ident: 94154_CR40 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-10-3152 – volume: 136 start-page: 215 year: 2009 ident: 94154_CR17 publication-title: Cell doi: 10.1016/j.cell.2009.01.002 – volume: 28 start-page: 3360 year: 2009 ident: 94154_CR28 publication-title: Oncogene doi: 10.1038/onc.2009.192 – volume: 35 start-page: 11137 year: 2014 ident: 94154_CR33 publication-title: Tumour Biol. doi: 10.1007/s13277-014-2412-0 |
SSID | ssj0000529419 |
Score | 2.3818014 |
Snippet | Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in malignant... Abstract Adrenocortical carcinoma is a rare aggressive disease commonly recurring regardless of radical surgery. Although data on genomic alterations in... |
SourceID | doaj swepub pubmedcentral proquest crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database Publisher |
StartPage | 14772 |
SubjectTerms | 631/337 631/67 Acid production Cancer Fatty acids Fatty-acid synthase Gene expression Genetic transformation Humanities and Social Sciences Inactivation Lipid metabolism MicroRNAs Mimicry miRNA multidisciplinary Multiple endocrine neoplasia Neuroendocrine tumors Nucleic acids Palmitic acid Pancreas Parathyroid Pituitary Science Science (multidisciplinary) Surgery Transcription Transfection Tumor cell lines Tumorigenesis |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQJSQuiKcIFGQkONGoie04znF5VBVSe6go6s2yM44aiSZVd1eI_h3-KDN2dml6KBduUeLYzjziGXvmG8beCd11nW5UruoWcmUUqpSsy1zICnTpVZBxK_voWB-eqq9n1dmNUl8UE5bggRPh9r1Ekx5cTRmPKihnpPYBCgeuCqJrYx45rnk3nKmE6i0aVTZTlkwhzf4SVyrKJqOIBLxU-fVsJYqA_TMr83aM5Pag9BaoaFyIDh6xh5MFyRdp5o_ZvTA8YfdTTclfT9nvo_4EqaFzecl_uiUHdLOvUsH5ANyt-AWF4J0cL3gq142D8bHjjjK6URTpehNkyMMAY0vpgXygQHNKuOS0Z8tL6iXscTcA74fz3pPhymO9v9TTiE5t3CXnLRUrGsYLx-mMgJNVu3zGTg--fPt0mE-VGPIWzY1VXpngG9BCOOFdYyrdurryHgApC4WiuCvoJHStQ3eqU67wvnEFYNsmGNcV8jnbGcYhvGAc0AN0SuNvBhoV0Q69QBvHF1CjYDiTsXLDFdtOMOVULeOHjcfl0tjESYuctJGT9jpjH7bvXCaQjjtbfyRmb1sSwHa8gWJnJ7Gz_xK7jO1uRMVOWr-06J5J2ZhC6Yy93T5GfSUCO-TUOrUxhEkkMlbPRGw2ofmToT-PyN9GoD2usfe9jTD-HfyuD36fBHY2wuf--yJ-8nptFaHEiZf_gzCv2ANBSlbU-APeZTurq3V4jXbbyr-JKvoH13RCPw priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4ilCCzISnGjUxHZi54SWR1UhtYeKor1ZduzQSDRZNruq6N_hjzLjPKr0sLdo47Vjz4w9M575hpD3LK-qKi9ELGTpYqEEiBSXacx45vLUCs-DK_v0LD-5EN-X2XJwuHVDWOW4J4aN2rUl-siPQPXlvFBgzn1a_YmxahTerg4lNO6TBwhdhiFdciknHwveYom0GHJlEq6OOjivMKcM4xLgUcQ3s_MowPbPdM27kZLTdekdaNFwHB0_IY8HPZIuesI_Jfd884w87CtL_n1O_p3W57AmecxX9Np01IGxve7LzntHzYZeYSDe-dmC9kW7YTDaVtRgXjcwJD6PoYbUN7A6mCRIGww3x7RLip5bmmIv_pCaxtG6uawtqq80VP3re2rBtA2-clpiyaKmvTIUbwoo6rbdC3Jx_O3Hl5N4qMcQl6B0bOJMeVu4nDHDrClUlpdGZtY6ByvrEoHRV67irioNGFWVMIm1hUkctC28MlXCX5K9pm38K0Id2IFG5LDZuEIEzEPLQNOxiZPAHkZFJB2possBrBxrZvzW4dKcK91TUgMldaCkvonIx-k_qx6qY2frz0jsqSXCbIcf2vUvPUitthzsSWckptsKL4ziufUuMc5knlWljMjByCp6kP1O33JqRN5Nr0FqcYENUGrbt1GITMQiImcsNvug-Zumvgz434qBVp5D74cjM94OvmvCH3qGnY3wtf65CFPebrVArDj2evec9skjhuKTSNhgD8jeZr31b0Av29i3Qfj-A7c3OOw priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3ba9YwFA9zIvgiXrFuSgR9csU2SdP08fPTMYTtYTjZW0ia1BVcOr4Lsv07_qOek16kQwa-hTaXNuec5JzknN8h5B2TTdPISqSirF0qlACR4mWeMl44mVvheTzKPj6RR2fi63lxvkPYGAsTnfYjpGVcpkfvsI9r2GgwGAwdCqAo0pt75D5CtyNXL-VyOlfBmyuRV0N8TMbVP5rO9qAI1T_TL297R05XpLfgROMWdPiYPBp0R7rov_YJ2fHhKXnQZ5O8fkZ-H7enMA8y5Vf0l1lTBwb2qk817x01G3qJznenJwvaJ-qGwWjXUIOx3MCEWB7dC6kPrqsxMJAGdDHHUEuKp7U0x178ATXB0TZctBZVVhoz_fU9dWDOxvNxWmOaotBdGoq3AxT12fVzcnb45dvyKB1yMKQ1KBqbtFDeVk4yZpg1lSpkbcrCWudgZl0m0OPKNdw1tQFDqhEms7YymYO6lVemyfgLshu64F8S6sD2M0LCAuMqEXEOLQPtxmauBJYwKiH5SBVdDwDlmCfjp44X5VzpnpIaKKkjJfVNQj5Mba56eI47a39CYk81EVo7PuhWP_TAatpysCGdKTHEVnhhFJfWu8w4U3jW1GVC9kdW0YO8rzUYZpxXKhMyIW-n1yCpOMEGKLXt6yhEI2IJKWcsNvug-ZvQXkTMb8VAE5fQ-8HIjH8Hv-uH3_cMOxvhc_t9EX95u9UC8eHYq__rdo88ZChOWQmL7D7Z3ay2_jXoZhv7JgrjH_LrN0Q priority: 102 providerName: Springer Nature |
Title | MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines |
URI | https://link.springer.com/article/10.1038/s41598-021-94154-z https://www.proquest.com/docview/2553398046 https://www.proquest.com/docview/2553819692 https://pubmed.ncbi.nlm.nih.gov/PMC8292366 https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-456302 https://doaj.org/article/b3871da734794e4a836bed0ada5e2fc7 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELf2ISReEJ8iMCojwRMLpI7jOA8IdWXTVKkVKhT1LbJjh1XaktEPwfbv8I9yZydFmaZJPCVKLnbiu4vv7LvfEfKGibIsRcZDnhYm5JKDSsVpP2RxYkRfcxu7pezxRJzO-GiezHdIW-6oGcDVra4d1pOaLc_f__559QkU_qNPGZcfVjAJYaIYBhvAKQ-vd8k-zEwpKuq4Mfc91jcDgqzJnbn90c785GD8O7bnzcjJ7fbpDahRNz2dPCQPGruSDrwgPCI7tnpM7vlKk1dPyJ_xYgpjJML4kv5SK2rA-V76MvTWULWmFxiYN50MqC_iDZ3RuqQK87xhoPC8DT2ktjJ1gUmDtMLwc0zDpLiSS_vYij2kqjJ0UZ0tNJqz1FUB9C3V4Oq6tXNaYAmjqr5QFHcOKNq6q6dkdnL8bXgaNvUZwgKMkHWYSKszIxhTTKtMJqJQaaK1MTCyJuIYjWXK2JSFAier5CrSOlORAdrMSlVG8TOyV9WVfU6oAb9QcQE_H5Nxh4GoGVg-OjIpiIuSAem3XMmLBrwca2ic524TPZa552QOnMwdJ_PrgLzbPnPpoTvupD5CZm8pEXbbXaiXP_JGi3Mdg39pVIrpt9xyJWOhrYmUUYllZZEG5KAVlbwV5RyctjjOZMRFQF5vb4MW4wAr4NTG00hEKmIBSTsi1nmh7p1qcebwwCUDK11A64etMP7r_K4PfusFttPD58X3gfvkzSbniB3HXvxfsy_JfYbqFKXwAz4ge-vlxr4Cu22te2Q3nac9sj8YjL6O4Hh0PPkyhatDMey5tZCeU9e_rllGwQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELdGJwQviE9RGGAk9sSipbaTOA8IdWzTxtYKVRvam2fHDqvEktIPTdu_wzt_I3dO0il76NveosY91_3dne_s-yDkE4vzPI9TEYgks4GQAkSKJ72A8cjGPSMc90fZg2F8cCq-n0Vna-RfkwuDYZWNTvSK2pYZnpFvg-nLeSrBnfs6-RNg1yi8XW1aaFRsceSur8Blm3053AV8Nxnb3zv5dhDUXQWCDLbOeRBJZ1IbM6aZ0amM4kwnkTHWhlzaUGAMkc25zTMNrkEudGhMqkMLY1MndR5yoPuArAsOrkyHrO_sDX-Mlqc6eG8GJOrsHKC4PYMdErPYMBICHkVw09oBfaOAlnV7NzZzeUF7p5ip3wD3n5InteVK-xWrPSNrrnhOHla9LK9fkL-D8QhQiAM-oVd6Ri2499Oq0b2zVM_pJYb-jYZ9WrUJh8lomVONmeQgAvjcBDdSVwAemJZICwxwx0RPimfFtIdU3BbVhaXj4mJs0GCmvs9gRakEZ9qfztMMmyQV5aWmeDdB0ZqevSSn94LVK9IpysK9JtQCXFrEoN5sKnyVRcPAtjKhTYAhteySXoOKyury6Nil47fy1_RcqgpJBUgqj6S66ZLPy-9MquIgK0fvINjLkVjY239QTn-pWk8ow8GDtTrBBF_hhJY8Ns6G2urIsTxLumSjYRVVa5uZupWNLvm4fA16Av9gDUgtqjESayGxLklaLNb6Qe03xfjCVxyXDPyAGKhvNcx4O_mqBW9WDNuaYXf8s--XvFgogdXp2JvVa_pAHh2cDI7V8eHw6C15zFCUwgTU-wbpzKcL9w6swrl5X4siJef3Lf3_ARggeTU |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3bbtMw1BpDIF4QV1EYYCT2xKKlthM7DwgVSrUxVqGJob0ZO3ZYJZaUXjRtv8Nf8HWc4ySdsoe-7S1q3OO65-JzP4S8ZWlRFGkmIiFzFwklgKW47EeMJy7tW-F5cGUfjtO9Y_HlJDnZIP_aWhhMq2xlYhDUrsrRR74Lqi_nmcKIZNGkRXwbjj5M_0Q4QQojre04jZpEDvzFOZhv8_f7Q8D1NmOjz98_7UXNhIEoh2t0ESXK28yljBlmTaaSNDcysda5mCsXC8wncgV3RW7ATCiEia3NTOxgbeaVKWIOcG-R25InfeQxeSJX_h2MoAGApk4H4O3O4a7EejbMiYBHEV127sIwMqCj517P0lyFaq-1NQ1X4egBud_osHRQE91DsuHLR-ROPdXy4jH5ezg5AnykEZ_SczOnDgz9WT3y3jtqFvQMkwCPxgNaDwyHzWhVUIM15cAM-NymOVJfAmawQJGWmOqOJZ8Uvca0j1D8DjWlo5PydGJRdaZh4mANqQKzOvjpaY7jksrqzFCMUlDUq-dPyPGNYOop2Syr0j8j1IENakQKgs5lIvRbtAy0LBs7CaRpVI_0W6zovGmUjvM6fusQsOdK15jUgEkdMKkve-Td6jvTuk3I2tUfEdmrldjiO3xQzX7pRmJoy8GWdUZiqa_wwiieWu9i40ziWZHLHtlqSUU3cmeur7ikR96sXoPEwD_YAKaW9RqFXZFYj8gOiXV-UPdNOTkNvccVA4sgBeg7LTFebb7uwNs1wXZ2GE5-DMKRl0stsE8de77-TK_JXeB5_XV_fPCC3GPISbEEOb9FNhezpX8J6uHCvgp8SMnPm2b8_ynufAU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-486-3p+was+downregulated+at+microRNA+profiling+of+adrenals+of+multiple+endocrine+neoplasia+type+1+mice%2C+and+inhibited+human+adrenocortical+carcinoma+cell+lines&rft.jtitle=Scientific+reports&rft.au=Li%2C+Su-Chen&rft.au=Monazzam%2C+Azita&rft.au=Razmara%2C+Masoud&rft.au=Chu%2C+Xia&rft.date=2021-07-20&rft.pub=Nature+Publishing+Group+UK&rft.eissn=2045-2322&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1038%2Fs41598-021-94154-z&rft.externalDocID=10_1038_s41598_021_94154_z |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |